Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Net Sales
1,196.42
Other Operating Income
0.00
Total Operating income
1,196.42
Raw Material Cost
102.29
Purchase of Finished goods
157.97
(Increase) / Decrease In Stocks
-23.74
Employee Cost
346.14
Power Cost
0.00
Manufacturing Expenses
0.00
Selling and Distribution Expenses
0.00
Other Expenses
373.78
Total Expenditure (Excl Depreciation)
956.44
Operating Profit (PBDIT) excl Other Income
239.98
Other Income
5.93
Operating Profit (PBDIT)
245.91
Interest
10.60
Exceptional Items
0.00
Gross Profit (PBDT)
235.31
Depreciation
37.16
Profit Before Tax
198.15
Tax
49.10
Provisions and contingencies
0.00
Profit After Tax
149.05
Extraordinary Items
0.00
Prior Period Expenses
0.00
Other Adjustments
0.00
Net Profit
149.05
Share in Profit of Associates
0.38
Minority Interest
0.00
Other related items
0.00
Consolidated Net Profit
149.43
Equity Capital
61.16
Face Value
10.0
Reserves
545.18
Earnings per share (EPS)
24.43
Diluted Earnings per share
24.43
Operating Profit Margin (Excl OI)
20.06%
Gross Profit Margin
19.67%
PAT Margin
12.49%
Public Share Holdings (%)
0.0%
Pledged Promotor Holding (%)
0.0%
Annual Analysis Highlights
Analysis not available as Data has been published for only 1 period
Compare Annual Results Of Corona Remedies With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
1,196.42
2,013.20
-816.78
-40.57%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,196.42
2,013.20
-816.78
-40.57%
Raw Material Cost
102.29
354.80
-252.51
-71.17%
Purchase of Finished goods
157.97
564.30
-406.33
-72.01%
(Increase) / Decrease In Stocks
-23.74
60.20
-83.94
-139.44%
Employee Cost
346.14
240.20
105.94
44.10%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
373.78
302.90
70.88
23.40%
Total Expenditure (Excl Depreciation)
956.44
1,522.40
-565.96
-37.18%
Operating Profit (PBDIT) excl Other Income
239.98
490.80
-250.82
-51.10%
Other Income
5.93
16.50
-10.57
-64.06%
Operating Profit (PBDIT)
245.91
507.30
-261.39
-51.53%
Interest
10.60
1.50
9.10
606.67%
Exceptional Items
0.00
61.90
-61.90
-100.00%
Gross Profit (PBDT)
235.31
468.10
-232.79
-49.73%
Depreciation
37.16
36.70
0.46
1.25%
Profit Before Tax
198.15
431.40
-233.25
-54.07%
Tax
49.10
117.70
-68.60
-58.28%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
149.05
313.70
-164.65
-52.49%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
99.60
-99.60
-100.00%
Net Profit
149.05
413.30
-264.25
-63.94%
Share in Profit of Associates
0.38
0.00
0.38
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
149.43
413.30
-263.87
-63.84%
Equity Capital
61.16
23.00
38.16
165.91%
Face Value
10.00
10.00
0.00
Reserves
545.18
837.60
-292.42
-34.91%
Earnings per share (EPS)
24.43
179.70
-155.27
-86.41%
Diluted Earnings per share
24.43
179.46
-155.03
-86.39%
Operating Profit Margin (Excl OI)
20.06%
24.38%
0.00
-4.32%
Gross Profit Margin
19.67%
23.25%
0.00
-3.58%
PAT Margin
12.49%
15.58%
0.00
-3.09%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 1,196.42 Cr
in Mar 2025Figures in Cr
Annual - Standalone Net Profit
Standalone Net Profit 149.05 Cr
in Mar 2025Figures in Cr
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 239.98 Cr
in Mar 2025Figures in Cr
Annual - Interest
Interest 10.60 Cr
in Mar 2025Figures in Cr
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.06%
in Mar 2025Figures in %
